After hours: December 12 at 6:16:44 PM EST ...
Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator. The FDA has cleared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback